Cerebellar glioblastoma multiforme in an adult

被引:25
|
作者
Hur, Hyuk [1 ]
Jung, Shin [1 ]
Jung, Tae-Young [1 ]
Kim, In-Young [1 ]
机构
[1] Chonnam Natl Univ, Hwasun Hosp & Med Sch, Dept Neurosurg, Hwasun 519809, South Korea
关键词
cerebellum; differential diagnosis; glioblastoma multiforme; pathogenesis;
D O I
10.3340/jkns.2008.43.4.194
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Primary cerebellar glioblastama multiforme (GBM) is a rare tumor in adults that accounts for just 1% of all cases of GBM. Due to their rarity, cerebellar GBMs are not yet completely understood about the pathogenesis and the prognosis. Here, we present a case of GBM in a 69-year-old man. Neurologic examination revealed the presence of cerebellar signs. Magnetic resonance imaging (MRI) showed a 4.5 x 3.6 cm-sized, ill-defined, heterogeneously enhancing mass in the left cerebellum and two patchy hyperintense lesions in the right cerebellum with minimal enhancement. After operation, glioblastoma was histologically confirmed. Postoperative radiotherapy with concomitant and adjuvant temozolomide chemotherapy was subsequently followed. Here, a case of unusual GBM in the cerebellum is reported with review of literature regarding the pathogenesis, the differential diagnosis and prognosis. There was no evidence of recurrence during postoperative one year. This patient showed a good prognosis in spite of the multiple lesions.
引用
收藏
页码:194 / 197
页数:4
相关论文
共 50 条
  • [31] Glioblastoma Multiforme Stem Cells
    Dimov, Irena
    Tasic-Dimov, Desanka
    Conic, Irena
    Stefanovic, Vladisav
    THESCIENTIFICWORLDJOURNAL, 2011, 11 : 930 - 958
  • [32] The DNA methylome of glioblastoma multiforme
    Martinez, Ramon
    Esteller, Manel
    NEUROBIOLOGY OF DISEASE, 2010, 39 (01) : 40 - 46
  • [33] Current Immunotherapies for Glioblastoma Multiforme
    Huang, Boyuan
    Li, Xuesong
    Li, Yuntao
    Zhang, Jin
    Zong, Zhitao
    Zhang, Hongbo
    FRONTIERS IN IMMUNOLOGY, 2021, 11
  • [34] Expression of Cytokeratins in Glioblastoma Multiforme
    Terada, Tadashi
    PATHOLOGY & ONCOLOGY RESEARCH, 2015, 21 (03) : 817 - 819
  • [35] Treatment of unresectable glioblastoma multiforme
    Nieder, C
    Grosu, AL
    Astner, S
    Molls, M
    ANTICANCER RESEARCH, 2005, 25 (6C) : 4605 - 4610
  • [36] Antiangiogenic therapies in glioblastoma multiforme
    McNamara, Mairead G.
    Mason, Warren P.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (05) : 643 - 654
  • [37] Advances in immunotherapy for glioblastoma multiforme
    Mahmoud, Ahmad Bakur
    Ajina, Reham
    Aref, Sarah
    Darwish, Manar
    Alsayb, May
    Taher, Mustafa
    AlSharif, Shaker A.
    Hashem, Anwar M.
    Alkayyal, Almohanad A.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [38] Nanotechnology for treatment of glioblastoma multiforme
    Michael, Justin S.
    Lee, Bong-Seop
    Zhang, Miqin
    Yu, John S.
    JOURNAL OF TRANSLATIONAL INTERNAL MEDICINE, 2018, 6 (03) : 128 - 133
  • [39] An unusual presentation of glioblastoma multiforme
    Joachim Baehring
    Eileen Ogle
    Charles Duncan
    Serguei Bannykh
    Journal of Neuro-Oncology, 2004, 70 : 341 - 342
  • [40] The Cure Fraction of Glioblastoma Multiforme
    Smoll, Nicolas R.
    Schaller, Karl
    Gautschi, Oliver P.
    NEUROEPIDEMIOLOGY, 2012, 39 (01) : 63 - 69